Summarized by Masters of Longevity from Science Daily - Health & Medicine.
Vitamin C and cancer survival: a short news article previewing a randomized trial testing daily oral supplementation and its clinical implications.
Key Takeaways
- The EVITA phase 2 randomized placebo-controlled trial evaluated oral vitamin C in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies.
- Patients receiving daily vitamin C experienced fewer adverse events compared with placebo during the trial period.
- The vitamin C arm showed a survival advantage signal compared with placebo, according to the reported trial results.
